News

Medpage Today on MSN5mon
FDA Approves New Option for Rosacea
Participants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard of care; or ...
Emrosi â„¢ (minocycline hydrochloride extended-release capsules ... with significant improvement of rosacea compared with doxycycline 40mg and placebo, based on the proportion of patients who ...
Emrosi â„¢ (minocycline hydrochloride extended-release capsules ... treatment with Emrosi was associated with significant improvement of rosacea compared with doxycycline 40mg and placebo, based on the ...